SPERO THERAPEUTICS INC (SPRO)
US84833T1034 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to SPRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.65. This target is 434.97% above the current price.
SPRO was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SPRO.
In the previous month the buy percentage consensus was at a similar level.
SPRO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-04 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-09-26 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-23 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-20 | Berenberg | Downgrade | Buy -> Hold |
| 2022-05-17 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-05-04 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-05-04 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-04-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-01 | Oppenheimer | Downgrade | Outperform -> Perform |